⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
OverviewScreenerAnalystsCalendar

Analyst actions

Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.

Ratings are attributed to the research firm, not to individual analysts. Latest event 15h ago.

All actionsUpgradesDowngradesInitiationsTarget raisesTarget cuts
7 days30 days90 daysHC Wainwright & Co. ✕
TickerFirmActionRatingTargetDate
AMLXAmylyx Pharmaceuticals, Inc.HC Wainwright & Co.MaintainedBuy$34 $55Aug 18
ARGXargenx SEHC Wainwright & Co.MaintainedBuy$940 $1,202Aug 18
CLMTCalumet, Inc.HC Wainwright & Co.

Showing the 12 most recent target moves.

Maintained
Buy
$60 $75
Sep 2
GENBGenerate Biomedicines, Inc.HC Wainwright & Co.MaintainedBuy$25 $30Aug 28
COAGHemab Therapeutics Holdings, Inc.HC Wainwright & Co.MaintainedBuy$52 $60Aug 11
ROIVRoivant Sciences Ltd.HC Wainwright & Co.MaintainedBuy$41 $471d ago
BLTEBelite Bio, IncHC Wainwright & Co.MaintainedBuy$214 $2451d ago
BLTEBelite Bio, IncHC Wainwright & Co.MaintainedBuy$200 $214Aug 12
ASNDAscendis Pharma A/SHC Wainwright & Co.MaintainedBuy$345 $344Aug 31
ASSTStrive, Inc.HC Wainwright & Co.MaintainedBuy$37 $36Aug 11
IONSIonis Pharmaceuticals, Inc.HC Wainwright & Co.MaintainedBuy$115 $1002d ago
VERAVera Therapeutics, Inc.HC Wainwright & Co.MaintainedBuy$125 $90Aug 12